Pharmaceutical Licensing Group
Life Science Leadership Series - Infectious Diseases and Vaccines
Location: Clare College, Cambridge
Date: 17 May 2012
Infectious Diseases and Vaccines will be the focus of the next One Nucleus Life Science Leadership Series event.
Q: What have the following companies in common?
Novartis, Enanta, Bristol Myers Squibb, Inhibitex, Celgene Corporation, Aliva Therapeutics, Gilead, Pharmasset, Roche, Anandys, Vertex and Alios
A: They have all been involved in major Hepatitis C drug development-related deals in the last year, with a collective headline value well in excess of $10Bn*
The size and frequency of announced deals in the Hep C space has been astonishing over recent months. Whilst there is scope for this to continue, it may also serve as an indicator of the growing interest and potential returns available in the anti-infective field with the discovery and development of new strategies of therapeutic intervention.
It seems timely therefore, that the next One Nucleus Life Science Leadership Series event to be held in Cambridge on 17 May 2012 is focussed on Infectious Diseases & Vaccines.
Advisory board:
Gerard Gregg-Smith, GGS Associates
Ken Powell, Q-CHIP Ltd
Richard Bax, Transcrip-partners
Fiona Marston, RFM Associates
Giuseppe Ciaramella, AstraZeneca
Steve Poile, Wildwood Ventures
A world class speaker list includes:
Tim Wells, Medicines for Malaria Venture
David McIntosh, Novartis Vaccines & Diagnostics
David Knowles, Procarta Biosystems
Barrie Wilkinson, Biotica Ltd
Deborah O’Neil, NovaBiotics
David Williams, Discuva Limited
Graham Clarke, ImmBio
Ted Fjällman, Cobra Biologics
Fiona Marston, Absynth Biologics
Mike Whelan, iQur Therapeutics
Gerard Gregg-Smith, GGS-Associates
Barbara Domayne-Hayman, Stabilitech
Neil Williams, KWS BioTest
Tom Saylor, Arecor
Steve Brocchini, Polytherics
Professor Sir Anthony Coates, St George’s University of London
*Current Agreements, “The Hep C club: the new dealmakers hot spot”, March 2012
For further information on this event and to register, please click here.